Primary hypogonadism is a condition that affects how the body produces testosterone and sperm, and managing it requires a careful balance between restoring hormone levels, addressing symptoms, and monitoring potential health risks throughout a person’s life.

How Treatment Helps Restore Health and Quality of Life

When primary hypogonadism is diagnosed, the main goal of treatment is to bring testosterone levels back into a healthy range so that the body can function properly again. This means addressing symptoms that can significantly affect daily life, such as reduced energy, changes in mood, decreased interest in sex, and physical changes like muscle loss or bone weakening. Treatment aims to restore and maintain the physical characteristics that depend on testosterone, support bone and muscle health, and help patients feel more like themselves again.^[1]

The approach to treatment depends heavily on when the condition started and what caused it. Someone who was born with primary hypogonadism will need a different treatment plan than someone who developed it later in life due to injury, infection, or other health problems. The stage of life also matters greatly. For young people who haven’t yet gone through puberty, treatment focuses on helping normal development occur at the right time. For adults, the emphasis shifts to managing symptoms and preventing complications like osteoporosis or heart problems.^[2]

Doctors follow clinical guidelines developed by professional medical societies when deciding how to treat primary hypogonadism. These guidelines are based on research studies and the collective experience of specialists who treat this condition regularly. The treatment plan is highly personalized, taking into account the patient’s age, symptoms, overall health, and personal goals. Some men are primarily concerned about sexual function, while others are more worried about fatigue, mood changes, or the risk of bone fractures.^[13]

It’s important to understand that while there are well-established treatments available, researchers continue to study new therapies that might offer better results or fewer side effects. Clinical trials play a crucial role in testing these innovative approaches before they become widely available.^[11]

Standard Treatment with Testosterone Replacement

The cornerstone of treating primary hypogonadism in adults is testosterone replacement therapy. This treatment involves giving the body testosterone from an external source to make up for what the testicles are no longer producing in sufficient amounts. The goal is to bring blood testosterone levels into the normal range, typically between 300 and 1000 nanograms per deciliter, though the ideal target can vary based on age and individual circumstances.^[7]

Testosterone replacement therapy comes in several different forms, each with its own advantages and disadvantages. The most common methods include intramuscular injections, transdermal patches that stick to the skin, gels that are applied to the skin daily, buccal patches that attach to the gum inside the mouth, and subcutaneous pellets that are implanted under the skin. Intramuscular injections are typically given every one to two weeks, though longer-acting formulations can last several weeks. These injections cause testosterone levels to rise quickly after administration and then gradually decline until the next dose.^[9]

Transdermal gels have become increasingly popular because they provide a steady release of testosterone throughout the day when applied to the shoulders, upper arms, or abdomen each morning. This mimics the body’s natural pattern of testosterone production more closely than injections. However, there is a risk of transferring the gel to other people through skin contact, which is particularly concerning if the patient lives with women or children. Careful handwashing and covering the application site with clothing helps prevent this.^[11]

Another option is testosterone undecanoate, an oral formulation that the lymphatic system (the network of vessels that helps remove waste and fight infection) absorbs, which means it may not cause the liver problems seen with older oral testosterone products. This offers the convenience of a pill taken with meals, though it requires taking multiple doses throughout the day.^[9]

The duration of testosterone therapy is typically long-term or lifelong for most patients with primary hypogonadism, since the underlying problem with the testicles usually cannot be reversed. Treatment is not simply about reaching a certain testosterone number on a blood test. The therapy should improve symptoms that were bothering the patient in the first place, such as low energy, reduced sex drive, or mood problems. If symptoms don’t improve even when testosterone levels normalize, doctors need to investigate other possible causes.^[10]

Clinical guidelines from the Endocrine Society recommend confirming the diagnosis of hypogonadism with at least two morning blood tests showing low testosterone, along with symptoms consistent with testosterone deficiency. Morning testing is important because testosterone levels naturally follow a daily rhythm, with the highest levels occurring in the early morning hours. Once treatment begins, healthcare providers adjust the dose based on both blood test results and how the patient feels.^[13]

Testosterone replacement therapy can produce significant improvements in multiple areas of health and wellbeing. Studies have shown that it can enhance sexual desire and function, increase muscle mass and strength, reduce body fat, improve bone mineral density (which helps prevent fractures), and positively affect mood and energy levels. Some men also notice improvements in concentration and memory. However, the degree of improvement varies from person to person.^[15]

Like any medical treatment, testosterone replacement therapy can cause side effects. Common ones include an increase in red blood cell production, which can thicken the blood and potentially increase the risk of blood clots. This is why doctors regularly check hematocrit, which measures the proportion of red blood cells in the blood. Some men develop acne or oily skin, experience mild fluid retention, or notice breast tissue enlargement. Testosterone replacement can also worsen sleep apnea in men who already have this condition.^[9]

One of the most important considerations is that testosterone replacement therapy suppresses sperm production. The external testosterone signals the brain to stop stimulating the testicles to make testosterone and sperm. This means that testosterone replacement is not appropriate for men who want to father children in the near future. For these patients, alternative treatments may be considered.^[10]

There has been significant discussion about whether testosterone replacement therapy affects cardiovascular health. Earlier studies raised concerns about potential increased risk of heart attacks or strokes, but a large, well-designed clinical trial found that testosterone replacement therapy did not increase the risk of major cardiovascular events, even in men at higher risk. Healthcare providers consider individual cardiovascular risk factors when prescribing testosterone therapy.^[15]

Testosterone replacement therapy is not appropriate for everyone. It should not be used in men with prostate cancer or breast cancer, as testosterone can potentially stimulate the growth of these cancers. Men with severe heart failure or severe sleep apnea should generally not receive testosterone therapy until these conditions are better controlled. Healthcare providers carefully review a patient’s complete medical history before starting treatment.^[13]

Alternative Approaches for Specific Situations

While testosterone replacement is the standard treatment for most men with primary hypogonadism, there are situations where other approaches might be considered. For men with primary hypogonadism who want to preserve or restore fertility, the challenge is that testosterone replacement itself shuts down sperm production. Unfortunately, for true primary hypogonadism where the testicles themselves are damaged, fertility options are limited because the problem lies within the organ that produces sperm.^[10]

In cases where young patients haven’t yet started puberty due to primary hypogonadism, treatment focuses on initiating puberty at an appropriate age. This involves starting with low doses of testosterone and gradually increasing them over several years to mimic the natural progression of puberty. This gradual approach helps ensure proper development of secondary sexual characteristics like facial hair, deepening of the voice, muscle development, and growth of the penis and testicles. The timing of when to start treatment takes into account the patient’s emotional and social development as well as their physical growth.^[10]

For patients who cannot tolerate certain forms of testosterone or who have specific concerns about particular delivery methods, switching between different formulations can help. Someone who experiences skin irritation from gel might do better with injections, while someone who dislikes needles might prefer a topical preparation. The variety of available testosterone products allows for individualized treatment plans.^[11]

Treatment Being Studied in Clinical Trials

Researchers are actively investigating new approaches to treating hypogonadism that might offer advantages over current testosterone replacement therapy. One particularly promising area of research involves selective androgen receptor modulators, often abbreviated as SARMs. These are molecules designed to activate the testosterone receptor in some tissues but not others. The goal is to achieve the beneficial effects of testosterone on muscle, bone, and sexual function while avoiding unwanted effects on the prostate and other organs.^[11]

Selective androgen receptor modulators work by binding to the same receptors in cells that testosterone normally activates, but they do so in a selective way. Think of them as keys that can unlock some doors but not others, whereas testosterone is a master key that unlocks all doors. This selectivity could potentially allow treatment of hypogonadism symptoms while minimizing side effects like prostate enlargement or excessive red blood cell production. However, these medications are still in clinical trials and are not yet approved for routine use in treating hypogonadism.^[11]

Another area of investigation involves different formulations and delivery methods for testosterone itself. Researchers are studying longer-acting testosterone preparations that would require less frequent dosing, which could improve convenience and patient adherence to treatment. Some studies are examining testosterone formulations that provide more consistent blood levels throughout the treatment interval, potentially reducing fluctuations in symptoms and side effects.^[11]

Clinical trials for hypogonadism treatments typically progress through several phases. Phase I trials focus primarily on safety, testing a new treatment in a small group of people to evaluate how the body processes it and what dose ranges might be appropriate. Phase II trials examine whether the treatment actually works to improve testosterone levels and hypogonadism symptoms, using a larger group of participants. Phase III trials compare the new treatment directly with standard testosterone replacement therapy or placebo in large groups of patients to definitively establish effectiveness and monitor for side effects.^[11]

Some research studies are also investigating whether certain supplements or medications might support testosterone production in men with mild primary hypogonadism. For example, researchers have studied whether aromatase inhibitors, which are drugs that block the conversion of testosterone to estrogen, might help improve testosterone levels in some patients. However, these approaches are still being evaluated and are not yet part of standard treatment guidelines for primary hypogonadism.^[11]

Studies examining transdermal dihydrotestosterone gel are also underway. Dihydrotestosterone is a potent androgen that the body normally makes from testosterone. Some researchers believe that direct application of this hormone might provide benefits while potentially having different effects on the prostate compared to testosterone itself. This remains an area of active investigation.^[11]

The eligibility criteria for clinical trials vary depending on what is being studied. Most trials have specific requirements regarding age, testosterone levels, symptom severity, and overall health status. Trials typically exclude patients with certain medical conditions or those taking medications that might interfere with the study results. Some trials focus specifically on men with primary hypogonadism, while others include both primary and secondary forms of the condition.^[11]

Preliminary results from some clinical trials of novel testosterone formulations have shown promising safety profiles and effectiveness in improving testosterone levels and symptoms. However, it’s important to remember that treatments being studied in clinical trials have not yet been proven safe and effective enough for widespread use. This is precisely why the trials are being conducted—to gather the evidence needed to determine whether new treatments should become available to all patients.^[11]

Most Common Treatment Methods

• Testosterone Replacement Therapy
  • Intramuscular injections of testosterone enanthate or cypionate, typically given every one to two weeks, though longer-acting formulations are also available
  • Transdermal testosterone gels applied daily to the skin, providing steady hormone levels throughout the day
  • Testosterone patches worn on the skin that release hormone continuously
  • Buccal testosterone tablets that attach to the gum inside the mouth and release hormone
  • Subcutaneous testosterone pellets implanted under the skin that slowly release hormone over several months
  • Oral testosterone undecanoate capsules taken with meals, absorbed through the lymphatic system
• Monitoring and Supportive Care
  • Regular blood tests to measure testosterone levels, typically in the early morning
  • Monitoring of hematocrit to check red blood cell levels
  • Prostate-specific antigen testing to monitor prostate health in men over 40
  • Bone density assessments to evaluate osteoporosis risk
  • Cardiovascular risk factor management including blood pressure and cholesterol monitoring
• Treatments for Initiating Puberty
  • Low-dose testosterone therapy gradually increased over time to mimic natural puberty progression
  • Starting with doses as low as 50 mg monthly and titrating up to adult replacement doses of 200-250 mg every two weeks
  • Monitoring of physical development and growth throughout treatment